BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25516222)

  • 21. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
    Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
    Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
    PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
    Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
    Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
    Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
    Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
    Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma.
    Hou X; Liang RB; Wei JC; Xu Y; Fu JH; Luo RZ; He JH; Zhang LJ; Lin P; Yang HX
    Oncotarget; 2016 May; 7(21):31088-96. PubMed ID: 27145270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
    Pignataro L; Pruneri G; Carboni N; Capaccio P; Cesana BM; Neri A; Buffa R
    J Clin Oncol; 1998 Sep; 16(9):3069-77. PubMed ID: 9738577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
    Noorlag R; Boeve K; Witjes MJ; Koole R; Peeters TL; Schuuring E; Willems SM; van Es RJ
    Head Neck; 2017 Feb; 39(2):326-333. PubMed ID: 27653309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
    Liu J; Wu Y; Wang Q; Liu X; Liao X; Pan J
    Future Oncol; 2018 Feb; 14(5):449-459. PubMed ID: 29322815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
    Mielcarek-Kuchta D; Olofsson J; Golusinski W
    Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.